Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_be4bc333907627cdd74d34caec782d98 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7edc1d0891976beb300b897e6afdf3c3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a9cc55c583fec8b4ee66e41c13e633ae http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0235b977566172502151387fdce32082 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c91af68c8b98fa096330236220fddd55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_981a37900e6991fb373304ed2ba5a703 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N47-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N25-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D251-16 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D251-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N47-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01P21-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01P13-00 |
filingDate |
2011-03-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c9708559403d2220a9670d6800d0d1a3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c8ba5fa393a73930922e59b19738ef03 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_951741024bbeb77fbda31471f2ec1c18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1328692854d2078372805ea839c14c85 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b24851af5b860e7aab0810e74df8e7f3 |
publicationDate |
2011-09-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2011107445-A1 |
titleOfInvention |
Hydrate and anhydrous crystal form of the sodium salt of 2-iodo-n-[(4-methoxy-6-methyl-1,3,5-triazin-2-yl)carbamoyl]benzenesulfonamide, process for preparation thereof and use thereof as herbicides and plant growth regulators |
abstract |
A hydrate and an anhydrous crystal form of the sodium salt of 2‑iodo-N-[(4-methoxy-6-methyl-1,3,5-triazin-2-yl)carbamoyl]benzenesulfonamide are described. These thermodynamically stable crystal forms have particular advantages in the stability of suspension formulations. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11753383-B2 |
priorityDate |
2010-03-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |